For hospitals, hospices, facilities, and death-care providers

A narrow release-and-custody interface for a patient who contacted IFA directly.

IFA's direct patient pathway does not ask a treating institution to market, endorse, sell, finance, or perform preservation. The immediate facility question is narrower: if a patient independently elected the pathway, can the ordinary lawful release and transfer process be prepared in advance?

The facility role

Ordinary care remains ordinary.

IFA does not ask a facility to change treatment, determine death for IFA, perform preservation, collect IFA payment, disclose patient lists, or recommend IFA. Where a patient has independently chosen the pathway, IFA seeks only the administrative coordination needed to avoid preventable delay after legal death.

Patient choice firstThe pathway begins with the patient or legally authorized representative. A facility does not need to sponsor or endorse IFA for an independently chosen case to be discussed.

What IFA may ask the facility to help identify

  • The appropriate operations, legal/risk, social-work, or disposition contact.
  • How the patient's disposition directive/provider information can be recorded under facility policy.
  • Who should receive an activation notice if death appears imminent.
  • The ordinary legal-death and release workflow.
  • Whether medical-examiner, coroner, autopsy, organ-donation, law-enforcement, or other holds may apply.
  • Where and to whom an authorized receiving provider should present for custody transfer.
What the facility is not being asked to do

No preservation procedure inside the treatment relationship.

  • No clinical endorsement or recommendation to purchase.
  • No patient list or marketing disclosure to IFA.
  • No referral compensation.
  • No collection or transmission of IFA payment.
  • No administration of preservation chemicals or technical preservation procedure by ordinary facility staff.
  • No change or delay in ordinary medical care.
  • No guarantee of future reconstruction, conversion, or outcome.
After legal death

Release remains controlled by law and facility procedure.

The facility continues its normal pronouncement, identity, reporting, medical-examiner/coroner, autopsy, organ-donation, infectious-disease, law-enforcement, family-authority, and release requirements. If release is lawful and the case is accepted, IFA coordinates the designated receiving/provider chain and documented transfer of custody.

Unexpected or reportable deathForensic and public-authority requirements are not bypassed. They take precedence where applicable.
A practical first call

Route the case; do not debate the entire program.

For a specific patient inquiry, the useful first step is to identify the person responsible for disposition/release operations and establish the facility's document and contact requirements. IFA can provide a concise workflow and patient-facing disclosure for legal/operations review.

Information IFA can provide

  • IFA company and case contact.
  • Patient/representative election and authority information, where available and appropriate.
  • Designated receiving-provider information.
  • Activation and release contacts.
  • Proposed custody-transfer documentation.
  • Current public status and claims boundaries.
Facility / provider contact

Route an independently elected Texas case.

IFA can send the three-page proposed workflow and patient disclosure for legal, operations, or clinical-administration review.

Samer E Said
Founder, President & CEO
Infrastructure for Agency Corporation

samer.e.said@ifacorporate.com